Recommendations to improve identification of hereditary and familial colorectal cancer in Europe

Hans F. A. Vasen1,2, Gabriela Möslein3, Ángel Alonso4, Stefan Aretz5, Inge Bernstein6, Lucio Bertario7, Ignacio Blanco8, Steffen Bülow9, John Burn10, Gabriel Capellá11, Chrystelle Colas12, Christoph Engel13, Ian Martin Frayling14, Nils Rahner5, Frederik J. Hes15, Shirley Hodgson16, Jukka–Pekka Mecklin∥17, Pål Møller18, T Myrhøj6, Fokko M. Nagengast19, Yann Parc20, Maurizio Ponz de Leòn21, Laura Renkonen–Sinisalo22, Julian R. Sampson14, Astrid Stormorken23, Sabine Tejpar24, Huw Thomas25, Juul T. Wijnen15, Jan Lubiński26, Heikki Järvinen22, Erna Claes27, Karl Heinimann28, John A. Karagiannis29, Annika Lindblom30, Isis Dove–Edwin25, Hj. Müller28
1Department of Gastroenterology, Leiden University Medical Centre, Leiden, The Netherlands
2Dutch Hereditary Cancer Registry and Department of Gastroenterology, Leiden University Medical Centre, AA Leiden, The Netherlands
3Department of Surgery, St. Josefs Hospital Bochum-Linden (Helios), Bochum, Germany
4Department of Medical Genetics, Hospital Virgen del Camino, Pamplona, Spain
5Institute of Human Genetics, University Hospital Bonn, Germany
6HNPCC-registry, Hvidrove Hospital, Hvidrove, Denmark
7Department of Surgery, Hospital Tumori, Milan, Italy
8Department of Genetic Counselling, Prevention and Cancer, Catelonian Institute of Oncology, Barcelona, Spain
9Department of Surgery, Hvidrove Hospital, Hvidrove, Denmark
10Institute of Human Genetics, Newcastle University, Newcastle upon Tyne, UK
11Catelonian Institute of Oncology, Barcelona, Spain
12Laboratoire d’Oncogenetique, Groupe Hospitalier Pitié-Salpêtre, Paris, France
13Institute of Medical Informatics, Statistics, and Epidemiology, University of Leipzig, Leipzig, Germany
14Institute of Medical Genetics, Cardiff, UK
15Department of Clinical and Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands
16Department of Clinical Genetics, St. George’s University of London, London, UK
17Department of Surgery, Jyvaskyla Central Hospital, Jyvaskyla, Finland
18Department of Genetics, Norwegian Radium Hospital, Oslo, Norway
19Department of Gastroenterology, University Medical Centre, Radboud, Nijmegen, The Netherlands
20Department of Digestive Surgery, Hospital Saint-Antoine, University Pierre et Marie, Paris, France
21Department of Internal Medicine, University Hospital, Modena, Italy
22Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland
23Department of Medical Genetics, Ullevål University Hospital, Oslo, Norway
24Digestive Oncology Unit, Department of Internal Medicine, University Hospital Gasthuisberg, Leuven, Belgium
25Department of Gastroenterology, Family Cancer Group, Cancer Research, UK CRC Unit, St. Mark’s Hospital, Harrow, Middlesex, UK
26International Hereditary Cancer Centre, Pomerian Medical University, Szczecin, Poland
27FAPA, Brussels, Belgium
28Division of Medical Genetics, University of Children’s Hospital, Basel, Switzerland
29Department of Gastroenterology, Konstantopoulio University Hospital, Athens, Greece
30Department of Molecular Medicine and Surgery, Karolinska Insitutet, Stockholm, Sweden

Tóm tắt

Từ khóa


Tài liệu tham khảo

Mecklin JP (1987) Frequency of hereditary colorectal carcinoma. Gastroenterology 93(5):1021–1025

Ponz de Leon M, Sassatelli R, Sacchetti C, Zanghieri G, Scalmati A, Roncucci L (1989) Familial aggregation of tumors in the three-year experience of a population-based colorectal cancer registry. Cancer Res 49(15):4344–4348

Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P et al (2005) Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352(18):1851–1860

Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. N Engl J Med 348(10):919–932

Vasen HF, Moslein G, Alonso A, Bernstein I, Bertario L, Blanco I et al (2007) Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 44(6):353–362

de Jong AE, Vasen HF (2006) The frequency of a positive family history for colorectal cancer: a population-based study in the Netherlands. Neth J Med 64(10):367–370

Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P et al (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118(5):829–834

de Jong AE, Hendriks YM, Kleibeuker JH, de Boer SY, Cats A, Griffioen G et al (2006) Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 130(3):665–671

Regula J, Rupinski M, Kraszewska E, Polkowski M, Pachlewski J, Orlowska J et al (2006) Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 355(18):1863–1872

Vasen HF, Moslein G, Alonso A, Aretz S, Bernstein I, Bertario L et al (2008) Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57(5):704–713

Umar A, Boland CR, Terdiman JP, Syngal S, de la CA, Ruschoff J et al (2004) Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96(4):261–268

van Dijk DA, Oostindier MJ, Kloosterman-Boele WM, Krijnen P, Vasen HF (2007) Family history is neglected in the work-up of patients with colorectal cancer: a quality assessment using cancer registry data. Fam Cancer 6(1):131–134

Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH et al (2006) Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 296(12):1507–1517

Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM et al (2003) Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349(3):247–257

de Vos tot Nederveen Cappel WH, Meulenbeld HJ, Kleibeuker JH, Nagengast FM, Menko FH, Griffioen G et al (2004) Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer. Int J Cancer 109(3):468–471

Overbeek LI, Ligtenberg MJ, Willems RW, Hermens RP, Blokx WA, Dubois SV et al (2008) Interpretation of immunohistochemistry for mismatch repair proteins is only reliable in a specialized setting. Am J Surg Pathol 32(8):1246–1251